6 results
algorithm management oncology afib bleed chads2vasc comparison diagnosis hasbled malignancy risk score stroke vte chemotherapy cyp3a4 inducers inhibitors interactions longterm
Stroke and bleeding risk stratification with the CHADS2-VASc and HAS-BLED schemas #Diagnosis #Hematology #CHADS2 #CHADS2VASc #HASBLED #Comparison
Stroke and bleeding ... stratification with the CHADS2 ... #Diagnosis #Hematology ... #CHADS2 #CHADS2VASc ... Stroke #Bleed #Anticoagulation
►
 Patient risk stratification algorithm for the treatment of cancer-associated thrombosis. Currently, edoxaban and rivaroxaban are the only
anticoagulants (DOACs ... filtration rate; DOAC ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology
►
 Treatment algorithm for VTE in Malignancy (A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
thrombosis in cancer ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... #Anticoagulation ... #Management #Hematology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓) of cytochrome p450 CYP3A4 and P-glycoprotein. DOACs are substrates
(DOAC interactions ... ) Cancer-treatment ... thereby leading ... metabolization leading ... Chemotherapy #Oncology #Hematology
CHA2DS2VASc vs HAS-BLED scores for stroke risk and bleed risk on anticoagulation C Congestive Heart Failure 1 H Hypertension 1 A2 Age >75 2 D Diabetes Mellitus 1 S2 Stroke,
bleed risk on anticoagulation ... S Stroke 1 B Bleeding ... drinks/week) 1 #CHADS2 ... Stroke #Bleed #Anticoagulation ... AFib #Diagnosis #Hematology
Longterm Venous Thromboembolism Treatment Algorithm Treat for 3 months and reassess • Isolated distal DVT (without cancer)
at 3 Months • Cancer ... PE - High Bleeding ... - Not High Bleeding ... Algorithm #management #hematology ... #anticoagulation
No results found for "bleeding ortho hematology gastroenterology anticoagulation hepatology cancer chads2 doac"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #bleeding #ortho #hematology #gastroenterology #anticoagulation #hepatology #cancer #chads2 #doac